Search for: "Holman"
Results 361 - 380
of 747
Sorted by Relevance
|
Sort by Date
9 Aug 2022, 5:53 pm
We already have several posts on the case in Patently-O: Dennis Crouch, The Sound of Silence and the Inherency Doctrine for Written Description, Patently-O (July 29, 2022) Chris Holman, Federal Circuit Flips “Negative Claim Limitation” Decision after Change in Panel Composition, Patently-O (June 23, 2022) Two groups of law professors have each filed an amicus brief in support of the petition. [read post]
26 Aug 2009, 6:12 am
The Corporate Gold Rush to Patent Your Genes’ perpetuates popular misperceptions surrounding gene patents (Holman's Biotech IP Blog) Australian pharmaceutical patent term extension for patches and implants: N V Organon; LTS Lohmann Therapie-Systeme AG and Schwarz Pharma Limited (Patent Baristas) China: Obama Administration and compulsory licensing in China (China Hearsay) China: Forty-two of Simcere’s generic drugs enter China’s Essential Drug List… [read post]
14 Sep 2011, 12:10 am
(Holman’s Biotech IP Blog) US: Classen v. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning… [read post]
23 Jun 2010, 2:45 am
Liz Holman gave the CBI view, rather uninspiring. [read post]
23 Nov 2021, 9:35 am
Holman. [read post]
15 Jun 2023, 2:20 pm
By Chris Holman In re Couvaras, 2023 WL 3984753 (Fed. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
7 Dec 2007, 4:18 am
Arthur came within hours of lethal injection at Holman prison on Sept. 27, when Gov. [read post]
15 Jul 2008, 4:00 am
Holman, __ F.3d _ (4th Cir. [read post]
19 Jul 2021, 1:36 pm
Holman, an inspiring advocate for her brother, told the Commercial Appeal. [read post]
15 Jul 2008, 4:00 am
Holman, __ F.3d _ (4th Cir. [read post]
16 Jul 2012, 9:53 am
“Public Citizen will continue demanding action until Congress finally lifts the veil of secrecy from money in politics,” Holman said. [read post]
22 May 2011, 9:51 pm
This reviewed a recent judgment from His Honour Judge Holman in Bank of Scotland v Whiteside (16 February 2011). [read post]
27 Oct 2010, 3:38 am
Highlights this week included: CAFC: Patentability of isolated genes Association for Molecular Pathology v USPTO and Myriad Genetics – Myriad files brief (Patently-O) (Holman’s Biotech IP Blog) (Holman’s Biotech IP Blog) Glivec (Imatinib) – Brazil: Supreme Court of Justice denies extension of Glivec patent (IP tango) Plavix (Clopidogrel) – US: $442 million fine against Apotex for Plavix patent infringement (GenericsWeb) (Philip Brooks’ Patent… [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description:… [read post]
30 Jan 2022, 9:01 pm
Holman Correctional Facility.There they heard a surprising presentation. [read post]
17 Feb 2013, 2:43 pm
Chris Holman (UMKC School of Law) has summarized the briefs supporting Bowman, and he submitted his own amicus brief on Monsanto's side, arguing that "[b]ecause of the ease with which genetically modified soybeans can be replicated by any user who comes into possession of even a single seed, whatever the source, enforceable patent protection is essential to maintain an adequate incentive for innovation." [read post]
12 Aug 2014, 6:56 am
And as the sale of the Holman Hunt proved, it doesn’t always go as hoped. [read post]
17 May 2023, 8:43 am
"ALSO in today's WSJ, a column by Holman W. [read post]
